Analyzing Discussion on Risk Analysis

Risk Analysis

How does a clinical trial contribute to risk analysis?

In the UK, clinical Trials Toolkit offers realistic advice to researchers in structuring and carrying out publicly funded trials via the utilization of an interactive route map. The Toolkit is majorly centered on CTIMPs (Clinical Trials of Investigational Medicinal Products) and the regulatory needs and environment related with these. However, R&D and researchers working in other fields shall also get significant data and guidance of relevance to the broader trials settings. Risk evaluation and mitigation entails application of statistical methods to choose significant factors having high research predicative values or sites which might be prone to noncompliance. It is claimed that prospectively arranged data-motivated and model-founded advances could assist optimize resources usage with maximal impact. Although the modeling exercise initiates objectivity in the hunt for significant risk factors, it should not by itself be seen as the only determinant of an optimal set. A sensible approach incorporates the findings of the model with subject-matter knowledge, taking into consideration significance and operational viability. It is observed that quantitative techniques have been suggested in fraud detection in clinical trials in the past. It is hence noted and sanctioned literature as a feasible tool for instituting risk evaluation initiatives in clinical trials. The initial step in developing risk mitigation initiatives via a quantitative exercise entails careful recognition and description of factors which have potential predictive value for noncompliance. The statistical procedures which could be utilized might vary from simple descriptive statistics to intricate model selection methods, depending on the availability of data. The dependent variable could be count or binary, where compliance inspection is the outcome of interest (Chappell, Knirsch, Alvir, & Alemayehu, 2012).

How is the task of risk analysis complicated by globalization?

In as much as globalization poses risks to global health, it offers significant benefits, too. The astonishing advancements in information technology have significantly increased the ease and speed of data flow, hence facilitating sharing of data. Medical breakthroughs made in one nation could be made almost immediately available to patients in other nations. It has also increased the speed of innovation by connecting researchers across the world to work cogently on the same issue, for instance, the response to SARS. Global cooperation of scientists connected via the internet resulted in the remarkably fast detection of the SARS virus as well as the development of a diagnostic test. World Health Organization (WHO), being the main international agency that handles global public health problems, plays an important role in the mitigation of health risks posed by globalization. The WHO has attempted to impose stricter control on tobacco use in its member countries through the Framework Convention on Tobacco Control (FCTC). The policies propose tax and price measures, safety from exposure to second-hand smoke, and control and revelation of the contents of tobacco products. It is hence important to expect future difficulties related to global health and to reflect on how to effectively respond, as globalization seems to be a permanent feature. The shifting of health experts from developing nations to the already developed nations jeopardizes the sustainability of health systems in the developing nations and this is one of the major issues that globalization has caused (Pang & Guindon, 2004). Under open economic circumstances, the conflict amidst the realization of internal economic equilibrium and external economic affectations is a major cause for consternation on the macroeconomic policies of the developing nations, lessening their capacity of macroeconomic regulation. A great volume of international floating capital has brought huge impacts on the financial stability and economic security of the developing nations, following constant discovery of new financial instruments, fast expansion of financial assets and the trend of privatization of international capital (Shangquan, 2000).